Overall rank by patents
#1,797
Across all tracked assignees
USPTO PatentsView assignee record — 227 granted patents across 24 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
ModernaTX, Inc. has been granted 227 US utility patents between 2016 and 2025, placing ModernaTX, Inc. at rank #1,797 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.7 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, ModernaTX, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 54.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 154 grants, compared with 73 in the 2015–2019 window — a +111% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. ModernaTX, Inc.'s 20.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ModernaTX, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
ModernaTX, Inc.
227 patents
What this shows ModernaTX holds 227 patents — placing it at rank #1,797 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 0.9% |
| 2017 | 13 | 5.7% |
| 2018 | 21 | 9.3% |
| 2019 | 37 | 16.3% |
| 2020 | 25 | 11.0% |
| 2021 | 22 | 9.7% |
| 2022 | 22 | 9.7% |
| 2023 | 26 | 11.5% |
| 2024 | 29 | 12.8% |
| 2025 | 30 | 13.2% |
Top 15 of 24 technology areas
Overall rank by patents
#1,797
Across all tracked assignees
54.6 out of 100
ModernaTX, Inc.'s primary CPC class — all holders and yearly trends
See where ModernaTX, Inc. ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.